Trump to nominate Scott Gottlieb as FDA commissioner despite industry links.
作者信息
Lenzer Jeanne
出版信息
BMJ. 2017 Mar 15;356:j1339. doi: 10.1136/bmj.j1339.
PMID:28298314
Abstract
摘要
相似文献
1
Trump to nominate Scott Gottlieb as FDA commissioner despite industry links.
BMJ. 2017 Mar 15;356:j1339. doi: 10.1136/bmj.j1339.
2
Scott Gottlieb and the Credibility of U.S. Therapeutics.
N Engl J Med. 2017 Apr 13;376(15):e30. doi: 10.1056/NEJMp1701738. Epub 2017 Mar 29.
3
An FDA Commissioner for the 21st Century.
N Engl J Med. 2017 Apr 13;376(15):e31. doi: 10.1056/NEJMp1703979. Epub 2017 Mar 29.
4
Ejecting the FDA from the courtroom.
Lancet. 2004;364(9435):638. doi: 10.1016/S0140-6736(04)16905-5.
5
Confronting the future of the FDA.
Natl J (Wash). 1996 Dec 14;28(50):2704-5.
6
Why the Watchdog Won't Bite: U.S. Food and Drug Administration Challenges.
West J Emerg Med. 2016 Nov;17(6):747-748. doi: 10.5811/westjem.2016.9.32492. Epub 2016 Nov 4.
7
The big gap at the FDA.
Fortune. 2002 Jul 22;146(2):113-4, 116.
8
Scott Gottlieb steps down from US FDA leadership.
Lancet. 2019 Mar 16;393(10176):1086-1087. doi: 10.1016/S0140-6736(19)30575-6. Epub 2019 Mar 14.
9
Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
Ann Intern Med. 2016 Oct 18;165(8):606-607. doi: 10.7326/L16-0031.
10
FDA dependence on drug industry.
J Natl Med Assoc. 2005 Jul;97(7):1039-40.
引用本文的文献
1
P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.
P T. 2018 May;43(5):293-300.
Zotero 插件